SEC Form 4 · accession 0001209191-15-034594
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Remy Luthringer
Officer — President, CEO & CSO · Director
Period of report
Apr 14, 2015
Accepted (ET)
Apr 16, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $5.19 | Apr 14, 2015 | A | 399,623 | A | — | Apr 13, 2025 | Common Stock | 399,623 | 399,623 | D |
Explanation of responses
- F1The exercise price is the closing price of the Issuer's common stock on April 14, 2015.
- F2This option shall vest as follows: 25% on April 14, 2016; and then in quarterly installments over 3 years thereafter.